Bharat Parenterals' Stock Sees Positive Start, Outperforms Sector by 1.05%
Bharat Parenterals, a smallcap pharmaceutical company, saw a positive start to its trading day with a 5% gain. This marks the second consecutive day of gains for the company, with a total increase of 5.75%. The stock also opened with a gap up of 5% and is currently trading above its moving averages. MarketsMojo has given a 'Sell' call for the company.
Bharat Parenterals, a smallcap pharmaceutical company, saw a positive start to its trading day as the stock opened with a gain of 5%. This outperformance was reflected in the stock's performance today, as it outperformed the sector by 1.05%. This marks the second consecutive day of gains for the company, with a total increase of 5.75% in the past two days.
The stock also opened with a gap up of 5%, indicating strong investor interest and confidence in the company. It reached an intraday high of Rs 1763.6, a 5% increase from its opening price. This positive momentum is further supported by the fact that Bharat Parenterals is currently trading above its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages.
In comparison to the overall market performance, Bharat Parenterals has shown a 1-day performance of 1.27% while the Sensex has seen a slight decline of -0.03%. Over the past month, the company has outperformed the Sensex with a 25.86% increase in its stock price, while the Sensex has only seen a 0.25% increase.
Based on these factors, MarketsMOJO has given a 'Sell' call for Bharat Parenterals. Investors should keep a close eye on the company's performance and market trends before making any investment decisions.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Most Read
